(S) -CCG-1423
(S) -CCG-1423 is the stereoisomeric form of the Rho signaling inhibitor CCG-1423. It functions by inhibiting the myocardin-related transcription factor A (MRTF-A) /serum response factor (SRF) pathway. This compound is utilized in cardiovascular and cancer research, demonstrating activity in both cellular and animal models of fibrosis and metastasis.
Product Specifications
Field of Research
Pharmacology & Drug Discovery, Signal Transduction
Smiles
O=C (NO[C@@H] (C) C (NC1=CC=C (Cl) C=C1) =O) C2=CC (C (F) (F) F) =CC (C (F) (F) F) =C2
Molecular Formula
C18H13ClF6N2O3
Molecular Weight
454.8
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
134638-HRP 100 µL
TPM3 (Tropomyosin alpha-3 Chain, Gamma-tropomyosin, Tropomyosin-3, Tropomyosin-5, hTM5) (HRP)
Sign In for Pricing
View Details 
MBS1362130-01 0.02 mg (E-Coli)
Recombinant Bungarus caeruleus Phospholipase A2 isoform 1
Sign In for Pricing
View Details